Skip to content
★ Sign in to follow
노

노광

선바이오선바이오
Insider activity · 24 months5 buys0 salesCumulative net flow
Total declarations
12
Company
1
▲ Purchases (12 ops.)
€105k
▼ Sales (0 ops.)
—

Latest filing published 09 Jun 2026 for 선바이오.

Filing timeline

BuySale
노광

Insider track record

Disclosed buys
12
Disclosed sells
0
Signal history

Closed purchases

Market purchases
12
Positive at T+90
60%
Median T+90
+9.0%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 02 Jun 2026 · 159 days ago · €14k
    -17.1%
    Entry ₩6,650 · Close 07 Oct 2026 ₩5,510
  • Filed 23 Apr 2026 · 199 days ago · €19k
    -25.8%
    Entry ₩8,100 · Close at T+90 ₩6,010
  • Filed 27 Mar 2026 · 226 days ago · €17k
    +11.0%
    Entry ₩5,460 · Close at T+90 ₩6,060
  • Filed 16 Mar 2026 · 237 days ago · €14k
    +17.0%
    Entry ₩5,110 · Close at T+90 ₩5,980
  • Filed 11 Mar 2026 · 242 days ago · €41k
    +9.0%
    Entry ₩5,020 · Close at T+90 ₩5,472

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

노광: trading record in brief

This profile gathers the share dealings of 노광 in 선바이오. In total, 12 filings cover trades dated from 22 February 2021 to 9 June 2026.

On the market, this insider has only ever bought: 12 purchases, €105k in total. The totals exclude 7 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 6 purchases and no sales on the market.

A typical purchase (the median) is worth €17k. Relative to company size, the median is 0.037% of market cap (5 purchases with a known value). Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 5 purchases show a median change of +9.0%, with the price up in 60% of them. They describe history only and say nothing certain about the share price ahead.

Most recently, on 9 June 2026, the filings show an open-market purchase in 선바이오. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Companies and markets linked to 노광

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ▲
    Executives선바이오
    0DART
    600 sharesShareKRXDART:20260609000216
    Canonical exit: 7 Sept 2026 (T+90)
  • ▲
    Executives선바이오
    25M KRW4DART
    4,200 shares@ ₩5,949.000.031% mcap19.5% of flowShareKRXDART:20260602000344
    Canonical exit: 31 Aug 2026 (T+90)
  • ▲
    대표이사Executives선바이오
    33M KRW28DART
    4,560 shares@ ₩7,137.000.042% mcap58.0% of flowShareKRXDART:20260423000113
    Canonical exit: 21 Jul 2026 (T+90)
  • ▲
    대표이사Executives선바이오
    29M KRW24DART
    5,300 shares@ ₩5,537.000.037% mcap23.3% of flowShareKRXDART:20260327000498
    Canonical exit: 24 Jun 2026 (T+90)
  • ▲
    대표이사Executives선바이오
    23M KRW26DART
    4,570 shares@ ₩5,104.50770.030% mcap42.0% of flowShareKRXDART:20260316000387
    Canonical exit: 9 Jun 2026 (T+90)
  • ▲
    대표이사Executives선바이오
    71M KRW28DART
    13,500 shares@ ₩5,295.77780.092% mcap57.2% of flowShareKRXDART:20260311003620
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    Executives선바이오
    0DART
    2,480 sharesShareKRXDART:20251105000092
    Canonical exit: 2 Feb 2026 (T+90)
  • ▲
    Executives선바이오
    0DART
    4,600 sharesShareKRXDART:20251001000325
    Canonical exit: 29 Dec 2025 (T+90)
  • ▲
    Executives(filed)선바이오
    0DART
    1,270,468 sharesKRXDART:20221116000099
    Canonical exit: 14 Feb 2023 (T+90)
  • ▲
    대표이사Executives(filed)선바이오
    0DART
    ShareKRXDART:20221017000165
    Canonical exit: 15 Jan 2023 (T+90)
  • ▲
    대표이사Executives(filed)선바이오
    0DART
    ShareKRXDART:20210415000181
    Canonical exit: 14 Jul 2021 (T+90)
  • ▲
    대표이사Executives(filed)선바이오
    0DART
    ShareKRXDART:20210222001494
    Canonical exit: 23 May 2021 (T+90)

12 of 12 declarations